Ades L, Guerci-Bresler A, Cony-Makhoul P, Legros L, Sebert M, Braun T, Delaunay J, Desseaux K, Chevret S, Fenaux P; GROUPE FRANCOPHONE DES MYELODYSPLASIES (GFM).

A phase II study of the efficacy and safety of an intensified schedule of azacitidine in intermediate-2 and high risk patients with myelodysplastic syndromes: a study by the Groupe Francophone des myelodysplasies (GFM).

Haematologica. 2018 Oct 31. pii: haematol.2018.203885. doi: 10.3324/haematol.2018.203885.